NCT04296929

Brief Summary

The aim of this study was to determine the effect of complex decongestive physiotherapy in women with unilateral breast cancer-related lymphedema on sensory parameters.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 28, 2019

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

March 2, 2020

Completed
3 days until next milestone

First Posted

Study publicly available on registry

March 5, 2020

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2021

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2021

Completed
Last Updated

March 5, 2020

Status Verified

March 1, 2020

Enrollment Period

1.3 years

First QC Date

March 2, 2020

Last Update Submit

March 3, 2020

Conditions

Outcome Measures

Primary Outcomes (3)

  • Touching sensation

    Assessment of touching sensation at 10 cm distal to the elbow on the volar surface in affected and unaffected arms at least 12 months after the breast cancer treatment, with Semmes-Weinstein Monofilaments in women with breast cancer related lymphedema.

    Change from Baseline touching sensation at 3 weeks

  • Two-point discrimination

    Assessment of two-point discrimination at 10 cm distal to the elbow on the volar surface in affected and unaffected arms at least 12 months after the breast cancer treatment, with an esthesiometer in women with breast cancer related lymphedema.

    Change from baseline two-point discrimination at 3 weeks

  • Pressure pain threshold

    Assessment of pressure pain threshold at 10 cm distal to the elbow on the volar surface in affected and unaffected arms at least 12 months after the breast cancer treatment, with an algometer in women with breast cancer related lymphedema.

    Change from baseline pressure pain threshold at 3 weeks

Secondary Outcomes (5)

  • Vibration sensation

    Change from baseline vibration sensation at 3 weeks

  • Ultrasonographic Imaging

    Change from baseline ultrasonographic imaging at 3 weeks.

  • Environmental measurement

    Change from baseline environmental measurement at 3 weeks.

  • Hot / Cold Sensory Test

    Change from baseline Hot/Cold sensory Test at 3 weeks

  • Lymphedema Life Impact Scale

    Change from baseline Lymphedema Life Impact Scale at 3 weeks.

Study Arms (2)

Affected arm in lymphedema patients

EXPERIMENTAL

Complex decongestive physiotherapy treatment will be applied to the arm (affected arm) that develops lymphedema after unilateral breast cancer treatment.

Other: Complex Decongestive Physiotherapy

Unaffected arm in lymphedema patients

NO INTERVENTION

After unilateral breast cancer treatments, the non-lymphedema side in the upper extremities, is the unaffected arm. No treatments will be applied to the unaffected side.

Interventions

Complete decongestive therapy (CDT), also called complex decongestive therapy, is an intensive program that combines many of the different treatment approaches, including bandaging, compression garments, manual lymphatic drainage, exercise, and self care.

Affected arm in lymphedema patients

Eligibility Criteria

Age18 Years - 80 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsThe study was planned in women with breast cancer related lymphedema.
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Clinical diagnosis of lymphedema disease
  • Ages between 18-80 years old,
  • cm difference between the affected and unaffected arms in women with breast cancer related lymphedema,
  • At least 12 months after breast cancer treatments end and
  • Who are agreed to participate in the study.

You may not qualify if:

  • Women with active infection,
  • deep vein thrombosis/thrombophlebitis,
  • cardiac edema,
  • peripheral artery disease,
  • kidney, lung disease,
  • primary lymphedema,
  • peripheral upper limb nerve injury,
  • any surgery other than breast cancer surgeries,
  • existing shoulder, elbow, wrist, hand pathologies,
  • cooperation problems,
  • neurological disease,
  • mental illness, diabetes mellitus,
  • smoking and patients with open wounds on the upper limb.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hacettepe University

Ankara, Samanpazari, 06100, Turkey (Türkiye)

RECRUITING

Related Publications (18)

  • Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015 Mar 1;136(5):E359-86. doi: 10.1002/ijc.29210. Epub 2014 Oct 9.

    PMID: 25220842BACKGROUND
  • Ribeiro Pereira ACP, Koifman RJ, Bergmann A. Incidence and risk factors of lymphedema after breast cancer treatment: 10 years of follow-up. Breast. 2017 Dec;36:67-73. doi: 10.1016/j.breast.2017.09.006. Epub 2017 Oct 6.

    PMID: 28992556BACKGROUND
  • Rijke AM, Croft BY, Johnson RA, de Jongste AB, Camps JA. Lymphoscintigraphy and lymphedema of the lower extremities. J Nucl Med. 1990 Jun;31(6):990-8.

    PMID: 2348245BACKGROUND
  • Goyal A, Newcombe RG, Chhabra A, Mansel RE. Morbidity in breast cancer patients with sentinel node metastases undergoing delayed axillary lymph node dissection (ALND) compared with immediate ALND. Ann Surg Oncol. 2008 Jan;15(1):262-7. doi: 10.1245/s10434-007-9593-3. Epub 2007 Sep 19.

    PMID: 17879117BACKGROUND
  • Wu SG, Huang SJ, Zhou J, Sun JY, Guo H, Li FY, Lin Q, Lin HX, He ZY. Dosimetric analysis of the brachial plexus among patients with breast cancer treated with post-mastectomy radiotherapy to the ipsilateral supraclavicular area: report of 3 cases of radiation-induced brachial plexus neuropathy. Radiat Oncol. 2014 Dec 12;9:292. doi: 10.1186/s13014-014-0292-5.

    PMID: 25499205BACKGROUND
  • Warmuth MA, Bowen G, Prosnitz LR, Chu L, Broadwater G, Peterson B, Leight G, Winer EP. Complications of axillary lymph node dissection for carcinoma of the breast: a report based on a patient survey. Cancer. 1998 Oct 1;83(7):1362-8. doi: 10.1002/(sici)1097-0142(19981001)83:73.0.co;2-2.

    PMID: 9762937BACKGROUND
  • Andersen KG, Duriaud HM, Kehlet H, Aasvang EK. The Relationship Between Sensory Loss and Persistent Pain 1 Year After Breast Cancer Surgery. J Pain. 2017 Sep;18(9):1129-1138. doi: 10.1016/j.jpain.2017.05.002. Epub 2017 May 11.

    PMID: 28502878BACKGROUND
  • Say CC, Donegan W. A biostatistical evaluation of complications from mastectomy. Surg Gynecol Obstet. 1974 Mar;138(3):370-6. No abstract available.

    PMID: 4811322BACKGROUND
  • Ganel A, Engel J, Sela M, Brooks M. Nerve entrapments associated with postmastectomy lymphedema. Cancer. 1979 Dec;44(6):2254-9. doi: 10.1002/1097-0142(197912)44:63.0.co;2-9.

    PMID: 509395BACKGROUND
  • Foldi M, Foldi E. [Therapy of lymphedema]. Med Welt. 1980 May 23;31(21):801-6. No abstract available. German.

    PMID: 6993841BACKGROUND
  • Lim CY, Seo HG, Kim K, Chung SG, Seo KS. Measurement of lymphedema using ultrasonography with the compression method. Lymphology. 2011 Jun;44(2):72-81.

    PMID: 21949976BACKGROUND
  • Voerman VF, van Egmond J, Crul BJ. Normal values for sensory thresholds in the cervical dermatomes: a critical note on the use of Semmes-Weinstein monofilaments. Am J Phys Med Rehabil. 1999 Jan-Feb;78(1):24-9. doi: 10.1097/00002060-199901000-00007.

    PMID: 9923425BACKGROUND
  • MOBERG E. Objective methods for determining the functional value of sensibility in the hand. J Bone Joint Surg Br. 1958 Aug;40-B(3):454-76. doi: 10.1302/0301-620X.40B3.454. No abstract available.

    PMID: 13575459BACKGROUND
  • Dellon AL. The moving two-point discrimination test: clinical evaluation of the quickly adapting fiber/receptor system. J Hand Surg Am. 1978 Sep;3(5):474-81. doi: 10.1016/s0363-5023(78)80143-9.

    PMID: 568154BACKGROUND
  • Granges G, Littlejohn G. Pressure pain threshold in pain-free subjects, in patients with chronic regional pain syndromes, and in patients with fibromyalgia syndrome. Arthritis Rheum. 1993 May;36(5):642-6. doi: 10.1002/art.1780360510.

    PMID: 8489541BACKGROUND
  • Weiss J, Daniel T. VALIDATION OF THE LYMPHEDEMA LIFE IMPACT SCALE (LLIS): A CONDITION-SPECIFIC MEASUREMENT TOOL FOR PERSONS WITH LYMPHEDEMA. Lymphology. 2015 Sep;48(3):128-38.

    PMID: 26939160BACKGROUND
  • Orhan C, Uzelpasaci E, Baran E, Nakip G, Ozgul S, Aksoy S, Akbayrak T. The Reliability and Validity of the Turkish Version of the Lymphedema Life Impact Scale in Patients With Breast Cancer-Related Lymphedema. Cancer Nurs. 2020 Sep/Oct;43(5):375-383. doi: 10.1097/NCC.0000000000000709.

    PMID: 30921030BACKGROUND
  • Baran E, Ozcakar L, Ozgul S, Aksoy S, Akbayrak T. Upper limb sensory evaluations and ultrasonographic skin measurements in breast cancer-related lymphedema receiving complex decongestive physiotherapy. Support Care Cancer. 2021 Nov;29(11):6545-6553. doi: 10.1007/s00520-021-06235-4. Epub 2021 Apr 29.

MeSH Terms

Conditions

LymphedemaBreast Neoplasms

Condition Hierarchy (Ancestors)

Lymphatic DiseasesHemic and Lymphatic DiseasesNeoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Study Officials

  • Türkan Akbayrak, Prof

    Hacettepe University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Emine Baran, PT, MSc

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Assistant, Physical Therapist, Master of Science

Study Record Dates

First Submitted

March 2, 2020

First Posted

March 5, 2020

Study Start

November 28, 2019

Primary Completion

March 1, 2021

Study Completion

December 1, 2021

Last Updated

March 5, 2020

Record last verified: 2020-03

Locations